SPIKEVAX BIVALENT (ORIGINAL / OMICRON BA.4/5)

moderna biopharma canada corporation🇨🇦 Health Canada

Approval Id: cf9c7f14b0637a41
Drug Approval Canada Name: SPIKEVAX BIVALENT (ORIGINAL / OMICRON BA.4/5)
Product Name: SPIKEVAX BIVALENT (ORIGINAL / OMICRON BA.4/5)
Status: Cancelled Post Market
Status Date: 2024-01-19
Original Market Date: 2022-11-25
Din: 02532352
Drug Class: Human
Dosage Form: Dispersion
Route Of Administration: Intramuscular
Schedule: Schedule D
Ahfs: 80:12.00
Atc Original: J07BN01 COVID-19, RNA-BASED VACCINE
Atc Name: j 07 bn 01
Aig Number: 0264201001
Company Name: moderna biopharma canada corporation
Company Address: 3130, 155 Wellington Street West, Toronto, Ontario, Canada, M5V 3H1

DAVESOMERAN

0.05 MG / ML

ELASOMERAN

0.05 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

cf9c7f14b0637a41

Type

Standard